Source:http://linkedlifedata.com/resource/pubmed/id/15809207
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-4-5
|
pubmed:abstractText |
Primary myeloma cells rapidly apoptose as soon as they are removed from their bone-marrow environment. A likely explanation is that the tumor environment produces survival factors that may counteract a spontaneous activation of pro-apoptotic program. Additional factors may trigger cell cycling in surviving myeloma cells. Interleukin-6 (IL-6) is a well recognized myeloma cell growth factor produced mainly by the tumor environment. However, myeloma cells themselves may produce low levels of autocrine IL-6. The respective roles of paracrine versus autocrine IL-6 are a matter of debate. We investigated these roles using the XG-6 myeloma cell line whose growth is dependent on addition of exogenous IL-6, despite its weak IL-6 mRNA and protein expression. The apoptosis induced by exogenous IL-6 deprivation was blocked by transferring the Mcl-1 gene coding for an anti-apoptotic protein in XG-6 cells. An XG-6Mcl-1 cell line which can survive and grow without adding IL-6 was obtained. We show that anti-IL-6 or anti-gp130 antibodies abrogated cell cycling whereas they did not affect cell survival. These data indicate that the weak autocrine IL-6 produced by myeloma cells is sufficient to trigger cell cycling whereas their survival requires large exogenous IL-6 concentrations. This important role of autocrine IL-6 has to be considered when evaluating the mechanism of action of myeloma cell growth factors. These factors may actually block an activated pro-apoptotic program, making possible a weak production of autocrine IL-6 to promote cell cycling.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/myeloid cell leukemia sequence 1...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1148-5493
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-64
|
pubmed:dateRevised |
2008-7-9
|
pubmed:meshHeading |
pubmed-meshheading:15809207-Antibodies, Monoclonal,
pubmed-meshheading:15809207-Apoptosis,
pubmed-meshheading:15809207-Autocrine Communication,
pubmed-meshheading:15809207-Cell Cycle,
pubmed-meshheading:15809207-Cell Line, Tumor,
pubmed-meshheading:15809207-Cell Survival,
pubmed-meshheading:15809207-Humans,
pubmed-meshheading:15809207-Interleukin-6,
pubmed-meshheading:15809207-Multiple Myeloma,
pubmed-meshheading:15809207-Neoplasm Proteins,
pubmed-meshheading:15809207-Paracrine Communication,
pubmed-meshheading:15809207-Proto-Oncogene Proteins c-bcl-2
|
pubmed:articleTitle |
Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
|
pubmed:affiliation |
INSERM U475, 99 rue Puech Villa, 34197 Montpellier Cedex 5, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|